https://biospectrumindia.com/rssfeed/states/assam assam https://biospectrumindia.com/news/105/28490/iit-g-researchers-develop-eco-friendly-bacterial-approach-to-treat-toxic-textile-dyes.html https://biospectrumindia.com/news/105/28490/iit-g-researchers-develop-eco-friendly-bacterial-approach-to-treat-toxic-textile-dyes.html Wed, 16 Sep 2026 14:30:43 +0530 A team of researchers at the Indian Institute of Technology Guwahati (IIT-G) has developed an eco-friendly biological approach to treat textile wastewater containing toxic azo dyes. The research provides a scientific foundation to develop biological treatment systems for textile wastewater containing azo dyes. The approach could offer an eco-friendly alternative or complementary treatment to conventional chemical and physicochemical methods. The research demonstrates the ability of a novel bacterium called ‘Brevundimonas sp. AJZ05’ to degrade 98.50% of Direct Blue-6 (DB-6), a widely used synthetic dye, while producing degradation products that were found to be non-toxic after bacterial treatment. The research was supported by the Ministry of Education, Government of India, through the Prime Minister's Research Fellowship (PMRF), with support from the Department of Chemical Engineering & Technology, IIT (BHU), Varanasi. Textile wastewater can contain azo dyes that are difficult to remove because of their stable chemical structure. These dyes contain an azo bond (–N=N–), which contributes to their colour and chemical stability, making them resistant to conventional treatment processes. Untreated textile effluents can pose risks to aquatic ecosystems and may have implications for human health. Conventional chemical and physicochemical treatment methods can also be energy-intensive and may generate secondary pollutants. Importantly, simply removing the visible colour from wastewater does not necessarily eliminate the underlying toxicity. Speaking about the current status of the research and the real-world applications, Dr Selvaraju Narayanasamy, Associate Professor, Biochemical and Environmental Engineering Laboratory, Department of Biosciences and Bioengineering, IIT Guwahati said, “We are now working towards translating the laboratory-scale findings into a practical and scalable wastewater treatment technology. The next step involves immobilising Brevundimonas sp. AJZ05 in a suitable support matrix to improve its stability, operational performance and reusability. We plan to develop a continuous treatment system for azo-dye removal from textile wastewater, with the long-term goal of advancing the microbial platform towards industrial application.” ]]> https://biospectrumindia.com/news/105/28266/iit-g-develops-device-for-rapid-detection-of-cancer-causing-heavy-metals-and-other-toxicants.html https://biospectrumindia.com/news/105/28266/iit-g-develops-device-for-rapid-detection-of-cancer-causing-heavy-metals-and-other-toxicants.html Fri, 07 Aug 2026 23:52:26 +0530 Researchers at the Indian Institute of Technology Guwahati (IIT-G) have developed an optical sensing device that can instantly detect a variety of toxicants in water and other biological samples. Aligned with the Government of India’s Jal Jeevan Mission, this innovation addresses a key challenge of ensuring safe drinking water. While the mission aims to provide tap water to every household, maintaining water quality remains a challenge due to different water sources, which may contain heavy metals and other disease-causing bacteria. To address this challenge of water quality monitoring, the research team has developed a portable point-of-care testing device named E-Eye. Working as an electronic eye, it detects multiple toxicants on-site while maintaining high accuracy, and transmits the recorded data wirelessly to water treatment facilities. E-eye works through a chemical reaction that produces a colored compound, in which color intensity highlights the concentration of the toxicants. Using basic optical principles, the device analyses the water and converts the sensor's output into digital data and displays the toxicant concentration. Contrary to conventional laboratory based costly instruments, E-Eye is suitable for direct field deployment, where it can detect water toxicants right at the water source. During laboratory tests, the research team found that results shown by E-Eye are comparable to those of standard UV-Visible and Atomic Absorption spectrophotometers (AAS),  while offering advanced digital integration functionality. The E-Eye device has been developed at a cost of approximately Rs 3,500, with a per-sample testing cost of around Rs 2. The cost of the device can be reduced further through large-scale industrial production. Other than water quality monitoring, the device is capable of analysing toxicants in environmental samples, biological samples, vegetables, food products, tea and herbal products, soil, and milk as well. The research team has tested more than 2700 samples with the developed device and recorded accurate results. Supported by a research grant from the Ministry of Electronics and Information Technology (MeitY), the research team has established a startup, ENVIONIX Labs, to commercialise the developed technology. Additionally, the team also plans to collaborate with an industry partner to initiate technology transfer and bring this innovation from lab to land.   ]]> https://biospectrumindia.com/news/105/28045/mrmed-establishes-physical-presence-in-guwahati.html https://biospectrumindia.com/news/105/28045/mrmed-establishes-physical-presence-in-guwahati.html Tue, 30 Jun 2026 15:32:04 +0530 Chennai-based startup MrMed, a direct-to-patient platform for critical care and super-specialty medicines, has announced the establishment of its physical presence in Guwahati. The move strengthens MrMed’s ability to serve patients across Northeast India, a region where access to high-value, tightly regulated medicines has historically been constrained by geography, limited pharmacy infrastructure, and the high cost of specialty therapies. Guwahati represents a natural  choice for MrMed. As the primary healthcare gateway for the Northeast, the city serves patients across Assam, Meghalaya, Manipur, Mizoram, Nagaland, Tripura, and Arunachal Pradesh, states where specialty pharmacy infrastructure remains sparse. For patients managing conditions such as cancer, HIV, hepatitis, rare diseases, or transplant-related therapies, the absence of reliable local access has long meant either travelling to distant metros or risking treatment interruption, both outcomes that carry serious clinical and financial consequences. MrMed’s Guwahati presence, comprising a physical store on Motilal Nehru Road in Kamrup Metropolitan staffed by a three-person team (a store manager plus executives managing orders and hub operations), is designed to directly address this gap, enabling faster fulfilment, improved treatment continuity, and significantly more affordable access to critical medicines for patients across the region.       Looking ahead, MrMed is progressing with plans to expand its physical presence and cold-chain infrastructure across additional cities in India including Mumbai, Hyderabad and more, with a sustained focus on geographies where patients currently face the greatest barriers to accessing specialty medicines. The company is also broadening its role within the healthcare ecosystem by entering allied super-specialty services, including home-based cancer care such as nurse-led infusions and pre- and post-chemotherapy support aimed at reducing hospital visits and improving continuity of care for patients on extended treatment cycles. ]]> https://biospectrumindia.com/news/105/27846/iit-guwahati-develops-security-technology-to-combat-fake-pharma-products.html https://biospectrumindia.com/news/105/27846/iit-guwahati-develops-security-technology-to-combat-fake-pharma-products.html Mon, 25 May 2026 14:15:03 +0530 Researchers at the Indian Institute of Technology (IIT) Guwahati have developed an advanced light-emitting perovskite nanomaterial that could improve protection against fake currency, forged documents, and other counterfeit products. To achieve this, the research team has developed nanocrystals capable of producing light-based security patterns that cannot be replicated using traditional printing and imaging methods. Counterfeiting has become a global concern affecting various industries, ranging from pharmaceuticals and electronics to banking and identity documentation. With the help of modern technologies, offenders have found ways to accurately copy conventional security measures such as barcodes, QR codes, holograms, and watermark labels. The research team has developed a double-layer coating around the nanocrystals, making them heat- and chemical-resistant while maintaining their light-emitting properties. Then, with the use of a direct laser writing technique, the team created tiny patterns from these materials. The multi-layer coating enabled the developed nanocrystals to create these patterns without using conventional lithographic masks, which helped in achieving resolutions of 10–40 micrometers, allowing very complex patterns and encoding of information. It is notable that the laser patterning technique developed by the IIT Guwahati research team can also be utilised in developing cutting-edge micro-LED displays for smartphones, wearables, and Augmented Reality (AR) systems, among others. On a broader scale, the developed technology can be applied across several sectors where product authentication and security are critical. ]]> https://biospectrumindia.com/news/105/27486/government-of-assam-approves-rs-700-cr-integrated-healthcare-hospitality-project-by-ambuja-neotia-group.html https://biospectrumindia.com/news/105/27486/government-of-assam-approves-rs-700-cr-integrated-healthcare-hospitality-project-by-ambuja-neotia-group.html Sun, 15 Mar 2026 00:00:00 +0530 Ambuja Neotia Group will develop a large integrated healthcare and hospitality project in Guwahati following the approval of its investment proposal by the Government of Assam, led by Chief Minister Himanta Biswa Sarma, for the development of a 300-bed multi-speciality hospital in the state. The project will be developed on a 2.88-acre mixed-use land parcel at Fancy Bazar, Old Jail Road, with a combined investment expected to exceed Rs 700 crore. The development will include a state-of-the-art 300-bed multi-speciality hospital and a premium 4+ star hotel with approximately 200–250 keys, reflecting a thoughtful approach to building infrastructure that strengthens both healthcare access and the city’s hospitality ecosystem. The Government of Assam has approved the allocation of the land parcel for the project, recognising its potential to contribute meaningfully to the state’s evolving healthcare capacity and urban economy. Of the total land area, 1.46 acres will be dedicated to the hospital, which will be developed by Ambuja Neotia Healthcare Venture Limited with an estimated investment of around Rs 360– Rs 400 crore. The hospital will offer advanced multi-speciality medical services across disciplines such as cardiology, neurology, orthopaedics, oncology and critical care, helping strengthen tertiary healthcare access for the state and the wider North-Eastern region. The remaining 1.42 acres will house a premium 4+ star hotel, to be developed by Ambuja Neotia Hotel Venture Limited, with an investment of approximately Rs 350 crore.  Together, the two developments are expected to generate significant employment opportunities, with the hospital alone projected to create 1,500–2,000 direct jobs, along with substantial indirect employment through allied services and local businesses. This will be the Group’s second healthcare initiative in Assam, following the successful launch of the Neotia Bhagirathi Woman and Childcare Centre in Guwahati in 2025, and reflects Ambuja Neotia Group’s expanding presence in the North-Eastern region. ]]> https://biospectrumindia.com/news/105/27219/icmr-hands-over-mobile-stroke-unit-to-government-of-assam.html https://biospectrumindia.com/news/105/27219/icmr-hands-over-mobile-stroke-unit-to-government-of-assam.html Thu, 22 Jan 2026 00:00:00 +0530 Stroke is one of the leading causes of death and long-term disability in India. Every minute is crucial in the event of a stroke—about 1.9 billion brain cells are destroyed per minute if treatment is delayed.  The Indian Council of Medical Research (ICMR) has handed over two Mobile Stroke Units (MSUs) to the Assam government to mitigate the serious problem. This is a significant shift towards quicker access to hospitals for stroke patients living in remote areas. Now hospitals are reaching out directly to patients. Developed under the leadership of Prime Minister Narendra Modi and guidance of Union Health Minister Jagat Prakash Nadda, this initiative reflects the government's commitment to ensure that even in the most challenging geographies, the poorest, the most vulnerable, and the most vulnerable populations, including women, have access to advanced healthcare services. MSU is a mobile hospital, equipped with CT scanners, teleconsultations from specialists, point-of-care laboratory, and blood clotting drugs. This enables early diagnosis and treatment of stroke at or near the patient's home. This innovation is particularly important for remote and hard-to-reach areas, where it can take several hours to reach hospitals. Through expert teleconsultation, MSU enables early identification of the type of stroke and quick initiation of treatment, saving lives and preventing disability. ]]> https://biospectrumindia.com/news/105/26961/iit-guwahati-pioneers-eco-friendly-solution-for-lead-removal-using-microorganisms.html https://biospectrumindia.com/news/105/26961/iit-guwahati-pioneers-eco-friendly-solution-for-lead-removal-using-microorganisms.html Fri, 21 Nov 2025 00:00:00 +0530 Researchers at the Indian Institute of Technology Guwahati (IIT-G) have developed a natural method to remove lead from contaminated water using cyanobacteria, microorganisms that are related to bacteria but are capable of photosynthesis. The developed method offers a sustainable and low-cost solution to one of the world’s most persistent environmental threats. The research team at IIT Guwahati has used bioremediation, a natural process in which microorganisms clean contaminated environments. These microorganisms naturally exist in soil and water and help in restoring ecological balance. To achieve this, the research team employed a light-dependent lead-bonding cyanobacterial species, “Phormidium corium NRMC-50”. The team researched the different parts of the cyanobacterium to examine which of the components were the most efficient to absorb and remove the lead contaminants. The researchers also demonstrated that cyanobacteria offer multiple environmental benefits such as absorbing pesticides, herbicides, hydrocarbons, synthetic dyes, and industrial chemicals, among others. The metals absorbed by the microorganisms can be recovered and converted into valuable products such as biochar, bioplastics, or biofuels. Considering these organisms are self-replicating, low-cost, and require only sunlight, carbon dioxide, and minimal nutrients, they offer a sustainable alternative to synthetic adsorbents currently being used globally. As the next step, the research team is targeting scaling the process from laboratory setup to a pilot-scale treatment system and testing it in real wastewater streams. ]]> https://biospectrumindia.com/news/105/26875/rj-corp-lays-foundation-of-cocoon-hospital-in-guwahati.html https://biospectrumindia.com/news/105/26875/rj-corp-lays-foundation-of-cocoon-hospital-in-guwahati.html Tue, 04 Nov 2025 00:00:00 +0530 In a major step towards strengthening healthcare infrastructure in Northeast India, RJ Corp Healthcare has laid the foundation stone for Cocoon Hospital, Guwahati — an advanced Mother & Child Care Hospital. The Bhumi Pujan ceremony was performed in the presence of Chief Minister of Assam, Dr Himanta Biswa Sarma, marking the beginning of a landmark healthcare project that will deliver world-class & affordable maternal and child healthcare services to the region. Planned as a 50-bedded NABH-accredited facility, Cocoon Hospital, Guwahati will be a state-of-the-art centre for maternity, gynaecology, IVF, paediatrics, and neonatal care. Spread across 1 acre, the hospital is designed to bring together advanced clinical infrastructure, expert medical teams, and a compassionate approach to care. Once operational, the facility will serve as a regional referral centre for the entire Northeast, offering comprehensive healthcare for women and children under one roof. Beyond clinical services, this initiative aims to make a significant social and economic impact in Assam by generating over 700 direct and indirect employment opportunities, partnering with local enterprises for procurement, logistics, and service delivery, and driving community well-being through preventive health camps, vaccination drives, and wellness programmes for women and children. Additionally, the project seeks to enhance health literacy and awareness through continuous outreach and educational initiatives — fostering a culture of preventive and inclusive healthcare across the state. The upcoming hospital will be equipped with modern operation theatres, digital diagnostic systems, and advanced neonatal intensive care, enabling a continuum of care for mothers and children. It is expected to be operational within the next 2 years, setting new benchmarks for quality and patient-centric healthcare in the Northeast. The foundation of Cocoon Hospital, Guwahati, marks the beginning of RJ Corp Healthcare’s strategic expansion into the Northeast.   ]]> https://biospectrumindia.com/news/105/26256/theos-life-sciences-begins-operations-in-northeast-india.html https://biospectrumindia.com/news/105/26256/theos-life-sciences-begins-operations-in-northeast-india.html Tue, 17 Jun 2025 00:00:00 +0530 Theos Life Sciences has officially unveiled its Northeast India operations with a grand launch event in Guwahati, marking a major step in its mission to expand access to affordable, high-quality healthcare across India. The event witnessed the participation of over 200 leading doctors of Guwahati and beyond, reflecting strong belief in Theos from the region’s healthcare fraternity. With a strong focus on research, and regional employment, Theos is poised to redefine pharmaceutical standards in the region through its two specialised divisions - NuGen and NuEra. Embodying the spirit of the “Make in India” initiative and aligning with push for growth and development of Northeast Region, Theos’ expansion brings not just a business footprint, but a vision. Co-founded by two industry leaders from Assam- Suresh Agarwala, a diversified entrepreneur with ventures in hospitality, real estate, and healthcare, and Manoj Kumar Modi, a leading name in pharmaceutical distribution, Theos operates from WHO-GMP certified facilities and aims to bridge the gap between medical excellence and affordability. Looking ahead, Theos plans to establish a world-class manufacturing facility and a cutting-edge research centre in Assam, focusing on research-driven molecules, innovation-led development, and significant local employment generation. ]]> https://biospectrumindia.com/news/105/26131/iasst-explores-use-of-neurotrophin-peptidomimetic-drugs-for-treating-neurodegenerative-disorders.html https://biospectrumindia.com/news/105/26131/iasst-explores-use-of-neurotrophin-peptidomimetic-drugs-for-treating-neurodegenerative-disorders.html Tue, 20 May 2025 00:00:00 +0530 A team of scientists at the Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of the Department of Science and Technology (DST), has been exploring peptidomimetics, synthetic compounds designed to mimic neurotrophins. Peptidomimetic drugs – or synthetic molecules that mimic the structure of natural proteins can be repurposed to provide an effective therapeutic strategy to treat neurodegenerative diseases (NDs) by promoting neuronal growth and survival. Neurotrophin peptidomimetics are developed to target specific biological functions and can be valuable tools in drug discovery, especially when natural peptides have limitations like poor oral bioavailability or susceptibility to degradation.  One of the significant advantages of peptidomimetics is their improved stability and bioavailability compared to endogenous neurotrophins. This means they can be delivered more effectively to the brain and maintain their therapeutic activity for a longer duration. Additionally, peptidomimetics can be designed to be more specific to their target receptors, reducing the risk of side effects. The researchers have highlighted the potential of peptidomimetics to treat NDs by promoting neuronal growth and survival. They have also explored the possibility of repurposing existing peptidomimetic drugs for other diseases, such as cancer, and the potential for developing new drug prototypes based on neurotrophins mimetics. As research progresses, the hope is that peptidomimetics could become a key therapeutic strategy, offering new hope for managing and treating neurodegenerative disorders for future generations. ]]> https://biospectrumindia.com/news/105/26035/iasst-develops-optical-sensing-platform-for-detecting-cholesterol-.html https://biospectrumindia.com/news/105/26035/iasst-develops-optical-sensing-platform-for-detecting-cholesterol-.html Fri, 25 Apr 2025 00:00:00 +0530 A team of interdisciplinary researchers at the Institute of Advanced Study in Science and Technology (IASST) in Guwahati, an autonomous institute under the Department of Science and Technology (DST, has developed an optical sensing platform for cholesterol detection based on silk fibre functionalised using phosphorene quantum dots. A point-of-care (POC) device has been developed in the laboratory scale for detecting cholesterol using this. It can sense cholesterol in trace amounts, even below the preferred range. It can be an efficient tool for routine monitoring of cholesterol levels in the human body. The synthesised sensors were highly sensitive as well as selective for cholesterol detection. Furthermore, the electrical sensing platform generates no e-waste, a key advantage of the fabricated device. Both sensing platforms respond similarly to real-world media such as human blood serum, experimental rat blood serum, and milk.  A highly sensitive, eco-friendly and cost-effective optical sensing platform developed for cholesterol detection can help identify early symptoms of diseases like atherosclerosis, venous thrombosis, cardiovascular diseases, heart disease, myocardial infarction, hypertension, and cancer. ]]> https://biospectrumindia.com/news/105/26019/iit-g-launches-4-year-bachelor-of-science-programme-in-biomedical-science-and-engineering.html https://biospectrumindia.com/news/105/26019/iit-g-launches-4-year-bachelor-of-science-programme-in-biomedical-science-and-engineering.html Tue, 22 Apr 2025 00:00:00 +0530 The Indian Institute of Technology, Guwahati (IIT-G) has announced the launch of its new four-year Bachelor of Science (BS) Programme in Biomedical Science and Engineering. The programme will be offered by the Jyoti and Bhupat Mehta School of Health Sciences and Technology (JBMSHST) at IIT Guwahati. A key highlight of the programme will include the collaborative learning experience with All India Institute of Medical Sciences (AIIMS) Guwahati and the National Institute of Pharmaceutical Education and Research (NIPER) Guwahati. Sharing his thoughts on the programme, Prof. Devendra Jalihal, Director, IIT Guwahati, said, “This interdisciplinary programme brings together engineering, medical sciences, and pharmacology on a single platform, addressing the need for professionals who can work across disciplines to tackle future challenges. As the problems of tomorrow will not fit into traditional silos, this program is designed to bridge those gaps. Supported by the Mehta Family Foundation and reviewed by leading experts from IIT Guwahati, AIIMS Guwahati and NIPER Guwahati, it is set to be a pioneering initiative." The application process for the programme will begin on 25th April 2025 and will remain open until 25th May 2025.  The programme will offer a strong academic foundation with comprehensive coursework spanning pre-clinical, para-clinical, and clinical domains. Students will gain hands-on skill development through specialised engineering modules designed to bridge the gap between technology and healthcare. A key feature of the programme is the clinical immersion experience, where students will have the opportunity to interact with leading surgeons and medical practitioners. Additionally, the curriculum boasts a cross-institutional learning framework in collaboration with AIIMS Guwahati and NIPER Guwahati to ensure exposure to diverse perspectives in biomedical science and engineering. From a career perspective, graduates of the program will find opportunities across a wide range of domains, including bioinstrumentation, biomedical devices, pharmacology and therapeutics, bioinformatics, and artificial intelligence, as well as research and development in health technology. ]]> https://biospectrumindia.com/news/105/25955/scientists-at-guwahati-nagaland-explore-use-of-magnetic-nanoparticles-for-cancer-treatment.html https://biospectrumindia.com/news/105/25955/scientists-at-guwahati-nagaland-explore-use-of-magnetic-nanoparticles-for-cancer-treatment.html Mon, 07 Apr 2025 00:00:00 +0530 An efficient magnetic system has been developed by a team of scientists from Guwahati-based Institute of Advanced Study in Science and Technology (IASST), an autonomous institute of Department of Science and Technology (DST), Govt. of India, in collaboration with National Institute of Technology (NIT) Nagaland, with newly systhesised nanocrystalline cobalt chromite magnetic nanoparticles that can treat cancer by increasing temperature  of tumour cells through a procedure called magnetic hyperthermia for treating cancer. Nanomagnets have opened up a targeted heat generation process (hyperthermia) that can be used in treating cancer cells with comparatively less side effects and is controlled by the magnetic field from outside. Tuning the physical properties of nanomagnets is essential to make them usable for hyperthermia applications. Due to the direct impact of various physical parameters of nanomagnets on the self-heating efficacy, it is challenging to create and control biofriendly coated magnetic nanoparticles with an effective heat generation efficiency. These magnetic nanoparticles' inhomogeneous in fluid form was used further to generate heat under the applied alternating magnetic field subjection. The heat generation method of magnetic nanoparticles can be used in treating cancer cells by elevating the cell temperature up to 46oC for a specific duration, causing necrosis in the injured cells when applied to particular cancer locations. Thus, superparamagnetic nanoparticles act as nano-heaters and can potentially be utilised in magnetic hyperthermia applications for treating cancer and offering alternative cancer therapy. ]]> https://biospectrumindia.com/news/105/25827/department-of-biotechnology-and-assam-govt-sign-historic-mou-for-centre-state-partnership-under-bioe3-policy.html https://biospectrumindia.com/news/105/25827/department-of-biotechnology-and-assam-govt-sign-historic-mou-for-centre-state-partnership-under-bioe3-policy.html Fri, 14 Mar 2025 00:00:00 +0530 The Department of Biotechnology (DBT) and the Government of Assam have signed a landmark Memorandum of Understanding (MoU) under the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy. This Centre-State partnership is the first of its kind under the BioE3 framework and aims to accelerate high-performance biomanufacturing while fostering a sustainable biotechnology ecosystem in Assam. The MoU signing is a culmination of extensive consultations, high-level meetings, and collaborative efforts made by the DBT and the Government of Assam. A landmark step in this journey was the Centre-State Partnership Conclave held last month under the chairpersonship of Union Minister of Science & Technology, Dr Jitendra Singh where the State Governments were encouraged to foster collaborations with the DBT and establish State BioE3 Cells. The MoU signed between DBT, and the Government of Assam formalises a strategic collaboration in which DBT will extend its guidance and facilitate partnerships, while the Government of Assam will spearhead initiatives by establishing a State BioE3 Cell and developing an Assam BioE3 Action Plan. This collaboration underscores Assam’s proactive approach to harnessing its rich biodiversity and agricultural strength to build a robust biomanufacturing ecosystem in the State. The MoU signing took place at DBT headquarters in New Delhi, in the presence of key dignitaries- Dr Rajesh S. Gokhale, Secretary, DBT, DG BRIC and Chairman BIRAC; Dr Ravi Kota, Chief Secretary, Government of Assam; Dr Alka Sharma, Senior Adviser/Sc‘H’, DBT; Pallav Gopal Jha, Secretary, Department of Science, Technology & Climate Change, Government of Assam; and Dr Jitendra Kumar, MD, BIRAC.   ]]> https://biospectrumindia.com/news/105/25805/auriga-research-signs-mou-with-assam-government-to-establish-pharma-testing-lab.html https://biospectrumindia.com/news/105/25805/auriga-research-signs-mou-with-assam-government-to-establish-pharma-testing-lab.html Mon, 10 Mar 2025 00:00:00 +0530 Auriga Research Private Limited, a trusted Indian leader in Testing, Inspection, and Certification (TIC) services, has signed two significant Memoranda of Understanding (MoUs) aimed at strengthening Assam’s food, pharmaceutical, and tea industries. The two agreements, signed with the Government of Assam and the Tea Research Association (TRA) during the Advantage Assam 2.0 Investment and Infrastructure Summit 2025, mark a transformative step toward enhancing quality assurance, regulatory compliance, and global competitiveness for Assam’s industries.  Auriga Research has partnered with the Government of Assam to establish an advanced testing laboratory for food, beverages, pharmaceuticals, Ayurveda, and medical devices. This state-of-the-art facility will be set up in Guwahati or Dibrugarh, with operations expected to commence within nine months. It will cater to both domestic businesses and export-driven industries, ensuring compliance with national and international quality standards. The Government of Assam will provide policy support, fast-track clearances, and facilitation services to ensure smooth implementation. This initiative aligns with Assam’s Ease of Doing Business (EoDB) policies and will further integrate the state into global supply chains, supporting India’s Make in India and Make for the World initiatives. Auriga Research will provide cost-effective, world-class testing solutions to producers, even small and mid-sized players to ensure compliance with stringent international regulations. ]]> https://biospectrumindia.com/news/105/25696/iit-g-signs-mou-to-promote-c-phycocyanin-production-technology-for-health-pharma-sectors.html https://biospectrumindia.com/news/105/25696/iit-g-signs-mou-to-promote-c-phycocyanin-production-technology-for-health-pharma-sectors.html Tue, 18 Feb 2025 00:00:00 +0530 In a major step towards bringing sustainable biotechnology solutions from lab to market, Indian Institute of Technology Guwahati (IIT-G) has signed a Memorandum of Understanding with K.N. Bioscience (India) Pvt. Ltd., for the large-scale commercialisation of C-Phycocyanin production from Spirulina biomass. The MoU was signed by Prof. Rohit Sinha, Dean Research & Development, IIT Guwahati, and Sudha Reddy, Founder and Managing Director, K.N. Bioscience (India), with Prof. Debasish Das, lead scientist behind the technology. C-Phycocyanin is a natural blue pigment derived from Spirulina, a type of cyanobacteria that grows using carbon dioxide and sunlight. It has multiple industrial applications, such as a natural blue food colorant, replacing synthetic dyes in confectionery, ice cream, and beverages; a nutraceutical and pharmaceutical compound, with anti-inflammatory, neuroprotective, and anti-diabetic properties; a fluorescent marker for diagnostics; a cosmetic ingredient for skin rejuvenation and wound healing; and a protein-rich aquafeed and poultry supplement for enhanced growth and disease resistance. Despite its immense potential, widespread adoption of this pigment is limited due to its high production costs and inefficiencies in extraction and purification. Currently, only a few Indian companies work with high-value microalgal products like phycocyanin and omega-3 oils, but this innovation opens doors for new industry players, boosts job creation, and strengthens India’s biotechnology industry. From a global point of view, this advancement can position India as a key exporter of this valuable compound. The technology has been successfully demonstrated at flask level experiments, 5L fermenter trials and 100L air lift flat plate photobioreactor. Additionally, a patent has been granted on the downstream process, developed by IIT Guwahati researchers for maximum extraction of C-phycocyanin from spirulina biomass and its purification to analytical-grade standard. Currently, the Technology Readiness Level (TRL) stands at 6, indicating its near-commercial viability. ]]> https://biospectrumindia.com/news/105/25673/iit-guwahati-innovates-flexible-heating-fabric-for-cold-climates-to-avoid-health-risks.html https://biospectrumindia.com/news/105/25673/iit-guwahati-innovates-flexible-heating-fabric-for-cold-climates-to-avoid-health-risks.html Thu, 13 Feb 2025 00:00:00 +0530 Indian Institute of Technology (IIT) Guwahati researchers have developed a water-repellent, conductive textile that converts electricity and sunlight into heat. Designed to keep wearers warm in cold environments, this innovation addresses the serious health risks posed by prolonged exposure to very low temperatures, including hemoconcentration-based arterial blood clotting, breathing difficulties, and weakened immunity. Extreme cold temperatures can lead to health problems that can even be fatal. Studies indicate that deaths due to extreme cold outnumber those caused by extreme heat. The textile can convert electricity using a small rechargeable battery or solar energy into heat and can maintain a desired temperature between 40°C and 60°C for over 10 hours. The researchers tested the textile in wearable knee and elbow bands, demonstrating its potential to provide sustained warmth for individuals working in cold environments and arthritis patients needing localized heat therapy. Additionally, the textile has broader applications, such as on-demand water heating and accelerating chemical reactions by wrapping it around the reaction vessels. The research team has filed an Indian patent on the innovation and is now working towards integrating the developed material with a miniaturised and appropriate electronic circuit to create viable products. Additionally, the team is seeking industry collaborations to bring the innovation to market for potential dry thermos-therapy applications in the near future.   ]]> https://biospectrumindia.com/news/105/25620/iit-g-designs-multi-stage-clinical-trial-method-for-revolutionising-personalised-medical-care.html https://biospectrumindia.com/news/105/25620/iit-g-designs-multi-stage-clinical-trial-method-for-revolutionising-personalised-medical-care.html Mon, 03 Feb 2025 00:00:00 +0530 Researchers at the Indian Institute of Technology Guwahati (IIT-G), in collaboration with leading institutions worldwide, have developed an innovative multi-stage clinical trial method aimed at revolutionising personalised medical care. This cutting-edge approach adapts treatment plans in real-time based on each patient’s unique responses during trials, enabling highly tailored and effective healthcare solutions. The research, conducted in partnership with Duke-NUS Medical School, the National University of Singapore, Singapore, and the University of Michigan, USA, focuses on Dynamic Treatment Regimes (DTRs) designed through Sequential Multiple Assignment Randomised Trials (SMARTs). Together, these frameworks tackle the critical challenge of optimising treatment strategies, a sequence of treatments, for patients with varying responses to therapies over time. Multi-stage clinical trials are essential for developing effective DTRs, and SMART methodology enables researchers to test various treatment sequences to find the best fit for each patient. Unlike traditional trials, SMART involves multiple stages of treatment, where patients are reassigned based on their responses to earlier interventions.  As a next step, the research team is collaborating with Indian medical institutions to conduct SMART trials for the effective management of mental health issues using traditional Indian medicines.   ]]> https://biospectrumindia.com/news/105/25598/iit-g-develops-state-of-the-art-nanomaterial-for-mercury-detection-in-cells-and-environment.html https://biospectrumindia.com/news/105/25598/iit-g-develops-state-of-the-art-nanomaterial-for-mercury-detection-in-cells-and-environment.html Mon, 27 Jan 2025 00:00:00 +0530 A team of researchers at the Indian Institute of Technology Guwahati (IIT-G) has developed an innovative approach to detecting harmful metals in living cells and the environment. Led by Prof. Saikat Bhaumik, Assistant Professor, Department of Physics,in collaboration with Prof. Chandan Goswami, Associate Professor, NISER Bhubaneswar, the team has introduced a cost-effective method for identifying toxic metals like mercury in human cells. This innovation could revolutionise disease diagnostics and environmental monitoring by improving the detection and management of metal toxicity in biological systems. Central to this research are perovskite nanocrystals, cutting-edge materials known for their exceptional properties, making them ideal for detecting metal ions. These nanocrystals, about 100,000 times smaller than a human hair, interact with light in significant ways, enabling them to serve as fluorescent probes inside living cells. However, their quick degradation in water has previously limited their applications. To address this, the researchers encapsulated the perovskite nanocrystals in silica and polymer coatings, significantly enhancing their stability and luminescent intensity in water. This modification ensures the nanocrystals maintain their functionality over extended periods, making them highly effective for practical use. The enhanced nanocrystals emit a bright green light under specific wavelengths, enabling precise detection of mercury ions, which are hazardous even in minute concentrations. Mercury exposure, whether through contaminated food, water, inhalation, or skin contact, poses severe health risks, including nervous system damage, organ dysfunction, and cognitive impairments. The team’s nanocrystals demonstrated remarkable sensitivity, detecting mercury levels as low as a few nanomolar concentrations. Moreover, when tested on live mammalian cells, the nanocrystals were found to be non-toxic, preserving cell function while effectively monitoring mercury ions. The potential applications of this research extend beyond mercury detection. These nanocrystals could play a pivotal role in identifying other toxic metals in biological systems and could also be adapted for drug delivery, enabling real-time monitoring of treatment efficacy.   ]]> https://biospectrumindia.com/news/105/25523/government-strengthens-healthcare-delivery-in-assam.html https://biospectrumindia.com/news/105/25523/government-strengthens-healthcare-delivery-in-assam.html Wed, 08 Jan 2025 20:00:00 +0530 Union Minister of Health and Family Welfare, Jagat Prakash Nadda visited key healthcare facilities in Assam, including the Lokopriya Gopinath Bordoloi Regional Institute of Mental Health (LGBRIMH), Mangaldai District Civil Hospital, and AIIMS Guwahati, to inaugurate new initiatives and review ongoing healthcare projects aimed at enhancing medical services for the people of the region During his visit to LGBRIMH in Tezpur, the Union Health Minister inaugurated the institute’s new Library and Informatics Centre. Expressing his satisfaction with the institute’s growth, Nadda emphasised the need to introduce more super specialty departments to better serve the Northeast and the nation as a whole. Nadda also visited Mangaldai District Civil Hospital in Darrang district, where he laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB). The CCB, to be constructed with a financial support of Rs 23.75 crore under Pradhan Mantri - Ayushman Bharat Health Infrastructure Mission, will significantly improve access to advanced healthcare services for the people of Assam. During his visit to Darrang, Nadda also inspected ongoing treatments at the cancer hospital and visited a cancer care project under Tata Trusts. He remarked, “Earlier, people had to travel out of state for cancer treatment, but now, the people of Darrang can receive their treatment right here at home.” ]]> https://biospectrumindia.com/news/105/25506/iit-guwahati-develops-innovative-injectable-hydrogel-for-targeted-breast-cancer-therapy.html https://biospectrumindia.com/news/105/25506/iit-guwahati-develops-innovative-injectable-hydrogel-for-targeted-breast-cancer-therapy.html Sat, 04 Jan 2025 00:00:00 +0530 In a multi-institutional research led by researchers from Indian Institute of Technology Guwahati (IIT-G) and Bose Institute Kolkata, an advanced injectable hydrogel has been developed for localised cancer treatment. This innovative hydrogel-based therapy delivers anti-cancer drugs directly to tumor sites, significantly reducing the side effects typically associated with conventional cancer treatments. Hydrogels are water-based, three-dimensional polymer networks capable of absorbing and retaining fluids. Their unique structure mimics living tissues, making them suitable for biomedical applications. This newly developed hydrogel acts as a stable reservoir for anti-cancer drugs and releases them in a controlled manner, responding to specific conditions in the tumor microenvironment. The hydrogel, composed of ultra-short peptides – biocompatible and biodegradable building blocks of proteins – is designed to remain insoluble in biological fluids, ensuring it stays localized at the injection site. It responds to elevated glutathione (GSH) levels, a molecule abundant in tumor cells. Upon encountering high GSH levels, the hydrogel triggers a controlled drug release directly into the tumor, minimizing its interaction with healthy tissues and reducing systemic side effects. In preclinical trials on a murine model of breast cancer, the hydrogel showcased remarkable efficacy. A single injection of the hydrogel, loaded with the chemotherapy drug Doxorubicin, resulted in a ~75% reduction in tumor size within 18 days. Crucially, the hydrogel remained localised at the tumor site, steadily releasing the drug over time without causing detectable side effects on other organs. This innovative delivery system enhances the drug's effectiveness while reducing the required dosage, thus minimising toxicity. ]]> https://biospectrumindia.com/news/105/25318/iit-guwahati-research-park-foundation-partners-with-assam-government-healthcare-foundation.html https://biospectrumindia.com/news/105/25318/iit-guwahati-research-park-foundation-partners-with-assam-government-healthcare-foundation.html Mon, 04 Nov 2024 00:00:00 +0530 In a landmark step to bolster research and development across sustainable urbanisation, healthcare innovation, and deep tech entrepreneurship, Indian Institute of Technology (IIT) Guwahati Research Park Foundation has signed three pivotal Memorandums of Agreement (MoAs). Through its partnership with the Assam Government - IIT Guwahati Healthcare Foundation, IIT Guwahati Research Park will host a corporate office and interim laboratory for the Assam Advanced Healthcare Innovation Institute (AAHII). Set to be a premier “Make in India” centre for medical technology, AAHII will specialise in diagnostics and treatment innovations aimed at reducing reliance on imported healthcare technology. The institute will house a postgraduate medical centre integrated with a super-specialty hospital and a cutting-edge research wing, bringing doctors and engineers together to drive indigenous healthcare advancements. Further, in collaboration with IIT-M Pravartak, IIT Guwahati Research Park will implement programmes focused on skilling, entrepreneurship, and deep tech innovation. Tailored to the Northeast’s needs, with particular emphasis on the semiconductor sector, this partnership seeks to strengthen industry-academia ties and bolster regional engagement in high-tech sectors. In partnership with CUBE, IIT Guwahati aims to develop an advanced urban infrastructure and sustainability hub at the IIT Guwahati Research Park. ]]> https://biospectrumindia.com/news/105/24946/glenmark-launches-boat-clinic-programme-to-enhance-maternal-and-child-health-in-assam.html https://biospectrumindia.com/news/105/24946/glenmark-launches-boat-clinic-programme-to-enhance-maternal-and-child-health-in-assam.html Mon, 29 Jul 2024 00:00:00 +0530 Glenmark Foundation has announced a strategic partnership with the Centre for North East Studies & Policy Research (C-NES) and the District Administration of Darrang to launch a pioneering boat clinic programme. This programme, focuses on maternal and child health by targeting the most vulnerable populations, to ensure children have a healthier start in life. It aims to deliver essential healthcare services to remote riverine communities, particularly addressing the challenges posed by seasonal flooding. This initiative aligns perfectly with the Glenmark Foundation’s “Healthy Children, Healthier World mission.” The boat clinic initiative is designed to overcome these challenges by providing a mobile healthcare unit that can navigate flood-affected regions with a special focus on women and children, who are the most vulnerable in difficult conditions. It will provide basic healthcare services, through a specially developed boat equipped with a laboratory and a pharmacy. A fully-fledged medical team, including doctors, nurses, lab technicians and pharmacists, will conduct regular health camps through a network of community health workers and organizers in the district. By offering services such as immunisations, prenatal care, and health education, the programme aims to ensure continuous healthcare access, improve health outcomes in these vulnerable areas and foster sustainable development.   ]]> https://biospectrumindia.com/news/105/24131/govt-invests-rs-100-cr-to-build-yoga-naturopathy-institute-in-assam-for-ncd-management.html https://biospectrumindia.com/news/105/24131/govt-invests-rs-100-cr-to-build-yoga-naturopathy-institute-in-assam-for-ncd-management.html Mon, 29 Jan 2024 00:00:00 +0530 The Union Minister of Ayush and Ports, Shipping & Waterways Sarbananda Sonowal along with the Chief Minister of Assam, Dr Himanta Biswa Sarma laid the foundation stone of the Central Research Institute of Yoga & Naturopathy (CRIYN) along with a 100 bedded Yoga & Naturopathy hospital at Dihing Khamtighat in Dibrugarh, Assam. The institution will be developed over a land parcel of nearly 15 acres (45 bighas) at an approximate investment of Rs 100 crore, with an aim at bringing a scientifically valid and useful synergy between traditional knowledge of Yoga and Naturopathy and modern tools of technology. It will establish benchmark standards in education, preventive healthcare and research in the field of Yoga and Naturopathy. This state-of-the-art institute will focus on fundamental aspects, scientific validation of traditional systems of medicine and practices through evidence-based research, apart from functioning as an international collaboration centre for global promotion and research in Yoga and Naturopathy. The institute will also serve as incubation centres in startups in the field of yoga and wellness sector. The institution will also offer clinical training facilities to train yoga and naturopathy experts for capacity building programmes in areas of cardiac rehabilitation, diabetes rehabilitation, autoimmune diseases and non-communicable diseases (NCDs) risk reduction. With research and development in the protocols of Yoga and Naturopathy, CRIYN will develop evidence-based protocols for management of NCDs that can be integrated with conventional care, reinforcing the integrated medicine approach of patient care. ]]> https://biospectrumindia.com/news/105/23948/c-camp-partners-with-assam-government-to-strengthen-public-healthcare.html https://biospectrumindia.com/news/105/23948/c-camp-partners-with-assam-government-to-strengthen-public-healthcare.html Tue, 12 Dec 2023 00:00:00 +0530 Building on the last three years’ effort of strengthening Assam’s public health system through world class, indigenous innovation, Bengaluru-based Centre for Cellular and Molecular Platforms (C-CAMP) has signed a Memorandum of Understanding (MoU) with the Medical Education & Research Department (ME&RD), Government of Assam towards focused innovation driven programmes for improving technology adoption by healthcare practitioners, infrastructure upgrades and capacity-building.  The MoU was signed at Dispur, Guwahati by C-CAMP Director and CEO, Dr Taslimarif Saiyed and Siddharth Singh, IAS, Commissioner and Secretary, Medical Education and Research Department on behalf of the Govt of Assam in presence of Health Minister, Keshab Mahanta. In Assam, C-CAMP has implemented 3 key healthcare programmes with funding support from national and international philanthropic organisations targeting important areas such as maternal and child healthcare, hospital infrastructure facility and immunisation including COVID-19 drives. 307 units of limited-resource, respiratory support technology have been implemented, to cover 100% infrastructure requirement for newborn and paediatric critical care to all district hospitals and medical colleges in Assam. A second project deployed 200 electronic temperature-regulated active vaccine carriers across 12 districts to strengthen last mile cold chain facilities for routine immunisation & COVID-19 vaccination. C-CAMP has also set up an oxygen-supported 54 bedded augmented hospital facility at Uluoni CHC under Simonabasti BPHC, Nagaon.  The immediate action point for the collaboration will be to intensify efforts in the above projects and align more emerging solutions with needs on the ground. In the immediate pipeline is a project to improve early screening and detection in Retinopathy of Prematurity, a common eye disease affecting premature babies and newborns through context-specific innovative health solutions.   ]]>